NIH to begin first human trial of Ebola vaccine next month

08/29/2014 | Vox

The National Institutes of Health will initiate a Phase I clinical trial of a vaccine for the Ebola virus in September, starting with three participants. The vaccine, jointly developed by the U.S. government and GlaxoSmithKline, is intended for use in high-risk people such as health care workers and in communities affected by an outbreak. The NIH intends to release preliminary findings from the trial later this year.

View Full Article in:

Vox

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR